Reactive oxygen species as mediators of signal transduction in cardiovascular disease

Trends in Cardiovascular Medicine

Volumn 8, Issue 2, 1998, Pages 59-64

  Abe, Jun Ichi ^a   Berk, Bradford C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; HEART INFARCTION; HUMAN; HYPERTENSION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SUDDEN DEATH; TRANSCRIPTION REGULATION; UNSTABLE ANGINA PECTORIS;

EID: 0031882260     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00133-3     Document Type: Review

References (52)

1. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee JD: 1996. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 271:16,586-16,590.
2. Abe J, Takahashi M, Ishida M, Lee J-D, Berk BC c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase (BMK1). J Biol Chem 272. 33:1997;20389-20394.
3. Alexander RW Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 25:1995;155-161.
4. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
5. - in vascular smooth muscle cells. Circ Res. 77:1995;29-36.
6. Berliner JA, Heinecke JW The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 20:1996;707-727.
7. Blenis J Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA. 90:1993;5889-5892.
8. Bolen JB, Rowley RB, Spana C, Tsygankov AY The Src family of tyrosine protein kinases in hemopoietic signal transduction. FASEB J. 6:1992;3403-3409.
9. Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouyssegur J Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene. 10:1995;1895-1904.
10. Cano E, Hazzalin CA, Mahadevan LC Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol. 14:1994;7352-7362.
11. Devary Y, Gottlieb RA, Smeal T, Karin M The mammalian ultraviolet response is triggered by activation of src tyrosine kinases. Cell. 71:1992;1081-1091.
12. Duff JL, Berk BC, Corson MA Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 188:1992;257-264.
13. Dugan LL, Creedon DJ, Johnson EM, Holtzman DM Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA. 94:1997;4086-4091.
14. -·), superoxide dismutases, and related matters. J Biol Chem 272:18,515-18,517.
15. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 316:1987;1371-1375.
16. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW Angiotensin II stimulates NADH and NADPH oxidase activation is cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148.
17. Gupta S, Campbell D, D'Erijard B, Davis RJ Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
18. Han J, Lee JD, Bibbs L, Ulevitch RJ A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
19. Irani K, Xia Y, Zweier JLet al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1997;1649-1652.
20. Javier SP, Mintz GS, Popma JJet al. Intravascular ultrasound assessment of the magnitude and mechanism of coronary artery and lumen tapering. Am J Cardiol. 75:1995;177-180.
21. Kakuta T, Currier JW, Haudenschild CCet al. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 89(6):1994;2809-2815.
22. Kyriakis JM, Banerjee P, Nikolakaki Eet al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
23. Lander HM, Ogiste JS, Teng KK, Novogrodsky A: 1995. p21ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem 270:21,195-21,198.
24. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension [see comments]. Circulation. 95:1997;588-593.
25. Lee JD, Ulevitch RJ, Han J Primary structure of BMK1: a new mammalian MAP kinase. Biochem Biophys Res Commun. 213:1995;715-724.
26. Losordo DW, Rosenfield K, Kaufman J, Pieczek A, Isner JM Focal compensatory enlargement of human arteries in response to progressive atherosclerosis: in vivo documentation using intravascular ultrasound. Circulation. 89:1994;2570-2577.
27. Marais R, Wynne J, Treisman R The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 73:1993;381-393.
28. Marui N, Offermann MK, Swerlick Ret al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 92:1993;1866-1874.
29. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE: 1996. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 93:12,908-12,913.
30. Mintz GS, Popma JJ, Pichard ADet al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 94:1996;35-43.
31. Muller JM, Cahill MA, Rupec RA, Baeuerle PA, Nordheim A Antioxidants as well as oxidants activate c-fos via Ras-dependent activation of extracellular-signal-regulated kinase 2 and Elk-1. Eur J Biochem. 244:1997;45-52.
32. Mulvany MJ, Baumbach GL, Aalkjaer Cet al. Vascular remodeling. Hypertension. 28:1996;505-506.
33. Nakamura K, Hori T, Sato N, Sugie K, Kawakami T, Yodoi J Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene. 8:1993;3133-3139.
34. Nunes GL, Sgoutas DS, Redden RAet al. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol. 15:1995;156-165.
35. - production in the pig coronary artery. Circulation. 96(10):1997;3593-3601.
36. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
37. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 92:1995;898-903.
38. Raingeaud J, Gupta S, Rogers JSet al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 270:1995;7420-7426.
39. Rao GN, Berk BC Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 70:1992;593-599.
40. Rao GN, Lassegue B, Griendling KK, Alexander RW, Berk BC Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: role of protein kinase C. Nucleic Acids Res. 21:1993;1259-1263.
41. Rao GN, Baas AS, Glasgow WC, Eling TE, Runge MS, Alexander RW: 1994. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J Biol Chem 269:32,586-32,591.
42. Rao GN, Alexander RW, Runge MS Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest. 96:1995;842-847.
43. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1993;1450-1456.
44. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G: evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest. 92:1993;1564-1571.
45. 2-induced T cell signal transduction. J Biol Chem 269:20,718-20,726.
46. Schulze-Osthoff K, Los M, Baeuerle PA Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol. 50:1995;735-741.
47. Starkebaum G, Harlan JM Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocystein. J Clin Invest. 77:1986;1370-1376.
48. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
49. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
50. Ushio F-M, Zafari AM, Fukui T, Ishizaka N, Griendling KK: 1996. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23,317-23,321.
51. Vasquez-Vivar J, Hogg N, Pritchard KA Jr., Martasek P, Kalyanaraman B Superoxide anion formation from lucigenin: an electron spin resonance spin-trapping study. FEBS Lett. 403:1997;127-130.
52. Zhou G, Bao ZQ, Dixon JE: 1995. Components of a new human protein kinase signal transduction pathway. J Biol Chem 270:12,665-12,669.